L-Arginine is a non-essential amino acid that is biosynthesized by protein metabolism. In certain cases, such as chronic infections and trauma, biosynthesis of L-Arginine is impaired in humans that result in biochemical abnormalities. Individuals without endogenous L-Arginine need external supplementation, and in such cases L-Arginine is considered as a semi-essential amino acid. Foods such as peanuts, milk, eggs and soy proteins are the richest sources of L-Arginine.
No information available
No information available
No specific information
Hypotension, nausea and diarrhoea are some of the reported adverse events of L-Arginine. IV administration of L-Arginine may increase the risk of metabolic acidosis in patients with electrolytic imbalance. In hepatic and renal disorder patients, L-Arginine can cause hypokalemia and azotemia due to impaired serum clearance.
Do not use L-Arginine in case of recent clinical history of acute heart attack.
No specific information
Some drugs such as statins and insulin may interact with L-Arginine. The plasma levels of isosorbide mononitrate, sodium nitroprusside and glyceryl trinitrate may be increased following L-Arginine administration.
No specific information
Oral dose of 6 – 30 g/day is being formulated in various brands for treatment of different ailments.
No specific information
Clinical trial data supporting safety and efficacy of L-Arginine in pregnancy and lactation is lacking. However, no significant adverse events are reported in gestational women.
No specific information
No specific information
No specific information
No specific information
Store at room temperature
Store at room temperature
You will hear from us only if the bid amount matches the minimum threshold and intended usage match our vision. You can resubmit another bid.